TuesdayMay 21, 2024 4:00 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Moving to Build Complete Entertainment Enterprise

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are positioning for opportunity. “Most recently, the company took a significant step forward in the development of Destino Ranch into a premier music, art destination with the acquisition of ABI Create, an innovative event management and production company. Founded by Marco Antonio Moreno, who was recently named president and COO of Lavish Entertainment, ABI Create has delivered high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions across the United States, including the NFL Super Bowl, San Diego and New York Comic Con…

Continue Reading

ThursdayMay 16, 2024 3:30 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant of overall drug effectiveness,” a recent article reads. “With this technology, Lexaria…

Continue Reading

WednesdayMay 15, 2024 3:55 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Journeys Toward Creation of One-of-a-Kind Destination

Golden Triangle Ventures (OTC: GTVH) is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors. GTVH and its entertainment division, Lavish Entertainment, are working with Cayenne Consulting on the strategic development of Destino Ranch. “Destino Ranch aims to redefine luxury entertainment and hospitality experiences. Set amid the breathtaking landscapes of the Mojave Desert, Destino Ranch will offer a unique blend of world-class entertainment, luxurious accommodations and immersive experiences. The destination location is designed to be an outdoor music and festival venue, immersive art installation and tourist attraction,” a recent article…

Continue Reading

ThursdayMay 09, 2024 11:57 am

HempNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Filling Void in Hemp and Cannabis Market

Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly owned subsidiary, AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market. “During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost, resulting in reduced profits. AgLAB’s Maximum Value Processing (‘MVP’) method uses the powerful AgLAB-1000-D2 mass spectrometer to test and to accurately configure the distillation system for optimal efficiency. The AgLAB MVP mass spectrometer and its rugged design are built to withstand the demands of the factory floor. The AgLAB-1000-D2 model offers real-time potency tests…

Continue Reading

TuesdayApr 23, 2024 3:55 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Making Significant Strides to Create Premier Entertainment Destination

Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, have made significant progress in transforming into reality the vision for a premier destination for year-round, world-class music, entertainment and art. “Since the announcement of Destino Ranch, a planned 638-acre property conveniently located within a short drive from large population centers such as Phoenix, Los Angeles and Las Vegas, Lavish Entertainment has officially activated the first phase of development. This phase includes the execution of a land-use-and-development agreement outlining exclusive rights to use and operate on the property. Phase one development will focus on the first nearly-70 acres of…

Continue Reading

ThursdayMar 28, 2024 3:33 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Focusing on ‘Overwhelming Interest’ for GLP-1 Applications of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that it will focus on glucagon-like peptide 1 (“GLP-1”) applications of its patented DehydraTECH(TM) technology for diabetes and weight loss for the 2024 calendar year. “This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH technology including its new foray into GLP-1 drugs… This laid the groundwork for Lexaria to explore a new class of molecules it had never worked on before, ultimately quietly launching its top-priority and unpublicized early-stage…

Continue Reading

FridayMar 08, 2024 2:59 pm

HempNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Subsidiary Tapping into Fast-Growing Opportunity

Astrotech (NASDAQ: ASTC), a science and technology company focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries, recently released financial results for Q2 2024. “The company recorded a 512% jump in its year-to-date (‘YTD’) revenue to $1,540,000 from $301,000 in the comparative period a year before. Astrotech attributed this growth primarily to two significant purchase orders for the TRACER 1000(TM) explosive trace detectors (‘ETDs’) to customers in Romania, which the company, through 1st Detect Corp., successfully delivered on. The subsidiary 1st Detect develops, manufactures and sells mass-spectrometer-based trace detectors – including the TRACER 1000(TM), the…

Continue Reading

FridayMar 01, 2024 3:45 pm

HempNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Breakthrough TRACER 1000(TM) Designed to Outperform Currently Used IMS Detectors

Astrotech (NASDAQ: ASTC) is a mass spectrometry company that, through its wholly owned subsidiary 1st Detect, has developed and rolled out the breakthrough TRACER 1000(TM) Explosive Trace Detector (“ETD”). “The world’s first mass spectrometry-based ETD certified by the European Civil Aviation Conference (‘ECAC’), the TRACER 1000(TM) is designed to outperform the ETDs currently used at aviation checkpoints as well as borders, cargo facilities and other secured points around the world. It is powered by the Astrotech Mass Spectrometer (‘AMS’) Technology that is inexpensive, smaller and easier to use when compared to traditional mass spectrometers. The AMS Technology works under ultra-high…

Continue Reading

WednesdayFeb 21, 2024 3:34 pm

HempNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Subsidiary Bringing ‘Game Changer’ Technology in AgLAB MVP

Astrotech’s (NASDAQ: ASTC) subsidiary AgLAB, Inc. has breakthrough mass spectrometry technology in its AgLAB 1000-D2 mass spectrometer and the Maximum Value Process(TM) testing method (“AgLAB MVP”). “AgLAB MVP is designed to improve yields and bottom-line profits for hemp (‘CBD’) and cannabis (‘THC’) producers of CBD-THC oils by up to 30%. Large-scale CBD and THC oil processors use molecular distillation systems (‘MDS’) to produce the valuable oils that are used in lotions, pills, tinctures, and cartridges. Using the AgLAB MVP solution, customers are now able to analyze the oils during processing and make near real-time adjustments that can boost the ending-weight…

Continue Reading

MondayFeb 12, 2024 3:37 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug to Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). “Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH-GLP-1 blood semaglutide level was about 261% higher than that of the control, a statistic that reflected…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722